Poland· PL-100369995

Tiocolis

A thiocolchicoside product containing thiocolchicosidum, registered in Poland by Biofarm Sp. z o.o.. The same ATC class is registered in 3 of our 19 countries.

ATC M03BX05

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedTiocolisATCM03BX05REGISTER NO.PL-100369995PACKS LISTED5CHECKEDSeptember 27, 2026

Where it is registered

Thiocolchicoside is registered in 3 of 19 countries.

Countries holding a registration under ATC M03BX05 (thiocolchicoside), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 3 of them publish a price we can compare per daily dose

Thiocolchicoside · ATC M03BX05

3 / 19 countries

  • Czechiaprice
  • Franceprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Thiocolchicosidum
Manufacturer
Biofarm Sp. z o.o.
Country
Poland (PL)
ATC code
M03BX05
ATC class
Thiocolchicoside
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 5

  • gtin
    05909991349059
  • gtin
    05909991349066
  • gtin
    05909991349073
  • gtin
    05909991349080
  • gtin
    05909991349097

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Thiocolchicoside in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All thiocolchicoside products

Authorised across Europe · EMA

The same active substance is authorised in 7 EEA countries. Names it is sold under:

  • Bulgaria · Tiyozid, Мускомед
  • Cyprus · Relief
  • Czechia · Muscoril
  • France · Miorel, Thiocolchicoside Almus
  • Greece · Haliver, Relief
  • Italy · Decontril, Miorexil
  • Portugal · Coltramyl, Relmus

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/abaf46c6-c8a2-4146-9696-a4db37e786be
GET /v1/drugs/abaf46c6-c8a2-4146-9696-a4db37e786be?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki",
  "source": "urpl",
  "strength": "4 mg",
  "packaging": "05909991349059 ¦ Rp ¦ 123612\n10 tabl.\n05909991349066 ¦ Rp ¦ 123613\n14 tabl.\n05909991349073 ¦ Rp ¦ 123614\n20 tabl.\n05909991349080 ¦ Rp ¦ 123615\n28 tabl.\n05909991349097 ¦ Rp ¦ 123616\n30 tabl.",
  "substance": "Thiocolchicosidum 4 mg",
  "common_name": "Thiocolchicosidum",
  "pl_product_id": "100369995",
  "pozwolenie_nr": "24311",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about thiocolchicoside.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.